Shield Therapeutics plc announced that Tim Watts, Shield's current CEO, will step down as CEO on 1 June 2021 but will remain with the Group as an executive Director until 30 September 2021 to ensure an effective transition at which point he will also step down from the Board. Greg will be appointed as a Director of the Company during June 2021 prior to which relevant Aim Rules disclosures will be made via a separate announcement.